logo
Area 51 veterans plagued by 'invisible illness' after working on top-secret projects

Area 51 veterans plagued by 'invisible illness' after working on top-secret projects

Daily Mail​18-07-2025
A group of US Air Force veterans has gone public with their story about how an 'invisible enemy' at the top-secret base Area 51 left them with cancer.
The former security guards at the Nevada Test and Training Range (NTTR) - a classified site that houses Area 51 - have claimed that the US government betrayed them and essentially handed them a death sentence without their knowledge.
Their claims stem from the revelation that NTTR was built in the 1970s on an area of land in the Nevada desert that was found to be contaminated with radiation from years of nuclear testing in the area.
However, that 1975 report from the US Energy Research and Development Administration also said it would 'be against the national interest' to stop the military's secret projects at the site.
According to David Crete, a former Air Force Sergeant who worked at NTTR from 1983 through 1987, over 490 of his fellow workers at the base have died of severe illnesses since being stationed at the secret facility.
Making matters worse, the US Department of Veterans Affairs has refused to cover their medical care because none of the surviving veterans can prove they were exposed to radiation near Area 51.
That's because their work was so top secret, all records of their activities have been marked as 'data masked.'
'I have brain atrophy. The left side of my brain is shrinking and dying. That's not too bad. I'm one of the healthy ones,' Crete told the House Veterans Affairs Committee in April while lobbying for legislation to support the Area 51 veterans.
Crete added that the average age of death for someone who served in that unit is 65 and the youngest airman to die was just 33.
The Air Force veteran was unaware of anyone who worked at NTTR who had lived beyond the age of 80, but the radiation exposure caused even more harm than that.
Along with revealing that most of his fellow airmen had developed multiple tumors since retiring, Crete told lawmakers that the radiation had been passed to their families as well.
'My wife had three miscarriages. One of the guys that I worked with, his wife had seven,' the veteran explained.
'All four of my children were born with birth defects or significant health problems. It's not their fault. I'm not saying it's mine, but I brought it home. It was my DNA that was permanently altered from low-dose, long-term, ionizing radiation exposure,' Crete continued.
In 2000, then-President Bill Clinton signed a bill that provided compensation and medical benefits to workers who developed illnesses due to exposure to radiation and other toxins while employed at certain government facilities, including nuclear sites.
Crete and other veterans from Area 51 who were invited to Washington on April 8 asked that the same healthcare rules that apply to these workers, who were not part of classified projects, apply to them as well.
Veteran Mike Nemcic told NewsNation: 'It's just a matter of betrayal. These folks knew, and they purposefully kept it quiet because it was more beneficial to them not to tell us.'
DailyMail.com has reached out to the Air Force for comment regarding this matter is still awaiting a response.
Crete and the other Area 51 veterans were employed by the Air Force's security police squadron to guard the F-117A Nighthawk, America's first stealth bomber, which was being developed and tested at the top-secret facility.
Most of what the airmen did at NTTR since the 1970s is still classified, and they've never been able to share what they were doing, not even to their families.
Veteran Pomp Braswell said: 'It felt very special, especially at a young age. My mom knew absolutely zero about what I was doing. She knew there was a phone number if she needed to get hold of me, that's it.'
According to Crete, the only recognition of their sacrifice at Area 51 came during a conversation with late US Senator John McCain, who served on the Senate Armed Services Committee and allegedly knew what was happening at NTTR.
'He came up to me and he said, 'Your unit ended the Cold War.' If you ever wanted validation that what you did was important, that's just about it,' Crete recounted.
Two bills have been introduced in Congress, the Protect Act and the Forgotten Veterans Act, to provide healthcare relief for the veterans affected by their classified work at NTTR.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs
WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs

The Independent

timea few seconds ago

  • The Independent

WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs

WeightWatchers was slower to adapt to the emergence of anti-obesity jabs than rivals, its boss has admitted, as the 62-year-old brand strives to catch up with rapidly evolving attitudes towards weight loss. Tara Comonte, chief executive of the US-based business, said it had a lot of work to do after going through a 'reset'. WeightWatchers recently announced it had emerged from bankruptcy after writing off a portion of the 1.15 billion US dollar (£860 million) debt on its balance sheet. It came as the business was competing with the emergence of GLP-1s – the scientific term for weight loss jabs, which work by reducing food cravings – and a new wave of apps and advice spreading on social media. Ms Comonte told the PA news agency that it 'wasn't as quick to medical weight loss solutions' as some other firms in the US, notably so-called 'telehealth' businesses that offer healthcare remotely. WeightWatchers, which runs some 20,000 workshops each month globally, is now 'at the beginning of the journey' towards forging a new place in the industry and meeting demand from current and future members, Ms Comonte said. 'This whole industry is going through somewhat of a reset and we have exciting work to do,' she told the PA news agency. 'This is a moment where, possibly more than ever before, people are talking about weight, and weight health… where people are seeking more education than ever before, and there are more voices than ever before.' Ms Comonte said the brand was known for 'trust and science' and it was important to harness that 'as there are more and more voices in the ecosystem'. WeightWatchers recently partnered with anti-obesity drugs provider CheqUp in the UK so patients taking the medication can access its 'companion' diet and lifestyle support app. It forms part of its efforts to muscle into the market by offering behavioural strategies and community-based support to people using or coming off the medication. 'There's no 'us and them' anymore,' Ms Comonte told PA, hitting back at weight loss jabs often being pitted as rivals to its model. Dr Kim Boyde, WeightWatchers' newly appointed chief medical officer, said not all its members will want or need weight loss medication – but stressed that it was 'imperative' the programme offers it to those that might benefit. Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs. Health officials have suggested that they can help to turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects.

The current testing system for prostate cancer is failing too many men
The current testing system for prostate cancer is failing too many men

Telegraph

timea few seconds ago

  • Telegraph

The current testing system for prostate cancer is failing too many men

SIR – Congratulations on your campaign (Leading Article, July 26) for a targeted screening programme for prostate cancer. My own diagnosis earlier this year made me realise that a national screening test is urgently needed. I was (and still am) asymptomatic, and have no known family history. I requested a PSA test from my GP following a chance meeting with an acquaintance who had recently been diagnosed with localised advanced prostate cancer – he had originally decided against a test, but was persuaded after learning of Sir Chris Hoy's experience. I am now being treated for localised advanced (high risk) prostate cancer. Your reports of men having to request a PSA test from their GP several times, even with symptoms, are appalling. A friend of a family member had a similar experience. He had experienced typical symptoms and went to see his GP, who gave him various blood and other tests, but notably not a PSA test. Having sought a second opinion privately, he was then diagnosed with prostate cancer, which has spread throughout his body. I know men who have received an unenthusiastic response from their GP; other men are completely ignorant of the cancer and its symptoms. The status quo is a disaster for men. I fully support your campaign and your call for better training and awareness for GPs. Geoff Stevens Harrogate, North Yorkshire SIR – I was repeatedly refused the PSA test by GPs on the grounds that the test was too sensitive and unreliable. I eventually managed to persuade a GP to comply, but only because I refused to be placed on statins, which were to be prescribed for no other reason than my age. The results of the test were elevated but, after treatment, at least I am now one of those who will die with, hopefully not of, prostate cancer. The worst irony of my experience was the revelation, from the nurse specialist who took my family history, that because my mother and maternal grandmother had both died of breast cancer, I was in a higher risk category. Had I known this, I might have convinced previous GPs to test my PSA earlier and maybe even qualified for prostatectomy, like younger friends and relatives with whom I have compared notes, thereby avoiding the unpleasant side effects of radiotherapy. Dermod Malley Halstead, Essex SIR – All men need to be tested for prostate cancer. My husband had no signs or symptoms, but we had lost a friend to the disease, so our enlightened GP ordered a PSA test which indicated that my husband, then 55, had a problem. Our son has been tested since he was 45 years old. My husband and his specialist fought it for 22 years but sadly he lost his battle in 2019. Marilla Blenkin Ashford, Kent

Roche to investigate whether new drug can delay or prevent Alzheimer's disease
Roche to investigate whether new drug can delay or prevent Alzheimer's disease

Reuters

timean hour ago

  • Reuters

Roche to investigate whether new drug can delay or prevent Alzheimer's disease

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store